127 related articles for article (PubMed ID: 18178637)
21. Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family.
Capra V; Consales A; Nozza P; Monti P; Inga A; Fronza G
Pediatr Blood Cancer; 2009 Feb; 52(2):303-4. PubMed ID: 18937320
[No Abstract] [Full Text] [Related]
22. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
Watanabe T; Vital A; Nobusawa S; Kleihues P; Ohgaki H
Acta Neuropathol; 2009 Jun; 117(6):653-6. PubMed ID: 19340432
[TBL] [Abstract][Full Text] [Related]
23. Primary carcinoma of the choroid plexus in Li-Fraumeni syndrome: case report.
Yuasa H; Tokito S; Tokunaga M
Neurosurgery; 1993 Jan; 32(1):131-3; discussion 133-4. PubMed ID: 8421542
[TBL] [Abstract][Full Text] [Related]
24. Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation.
Rossbach HC; Baschinsky D; Wynn T; Obzut D; Sutcliffe M; Tebbi C
Pediatr Blood Cancer; 2008 Mar; 50(3):681-3. PubMed ID: 17427234
[TBL] [Abstract][Full Text] [Related]
25. Foetal loss and infant deaths in families of children with soft-tissue sarcoma.
Hartley AL; Birch JM; Blair V; Kelsey AM; Morris Jones PH
Int J Cancer; 1994 Mar; 56(5):646-9. PubMed ID: 8314340
[TBL] [Abstract][Full Text] [Related]
26. Patterns of cancer in the families of children with soft tissue sarcoma.
Hartley AL; Birch JM; Blair V; Kelsey AM; Harris M; Jones PH
Cancer; 1993 Aug; 72(3):923-30. PubMed ID: 8334646
[TBL] [Abstract][Full Text] [Related]
27. Orbital rhabdomyosarcoma in Li-Fraumeni syndrome.
Chong DY; Demirci H; Ronan SM; Flint A; Elner VM
Arch Ophthalmol; 2007 Apr; 125(4):566-9. PubMed ID: 17420382
[No Abstract] [Full Text] [Related]
28. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome.
Rieber J; Remke M; Hartmann C; Korshunov A; Burkhardt B; Sturm D; Mechtersheimer G; Wittmann A; Greil J; Blattmann C; Witt O; Behnisch W; Halatsch ME; Orakcioglu B; von Deimling A; Lichter P; Kulozik A; Pfister S
Genes Chromosomes Cancer; 2009 Jul; 48(7):558-68. PubMed ID: 19378321
[TBL] [Abstract][Full Text] [Related]
29. Prenatal diagnosis history of a Li-Fraumeni syndrome family.
Güran S; Tunca Y
Cancer Genet Cytogenet; 2005 Mar; 157(2):191. PubMed ID: 15721647
[No Abstract] [Full Text] [Related]
30. The genetics of cancer.
Malkin D
J Insur Med; 1993; Suppl B():229-36. PubMed ID: 10146358
[No Abstract] [Full Text] [Related]
31. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.
Kouidou S; Malousi A; Maglaveras N
Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569
[TBL] [Abstract][Full Text] [Related]
32. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
[TBL] [Abstract][Full Text] [Related]
33. 2009 version of the Chompret criteria for Li Fraumeni syndrome.
Tinat J; Bougeard G; Baert-Desurmont S; Vasseur S; Martin C; Bouvignies E; Caron O; Bressac-de Paillerets B; Berthet P; Dugast C; Bonaïti-Pellié C; Stoppa-Lyonnet D; Frébourg T
J Clin Oncol; 2009 Sep; 27(26):e108-9; author reply e110. PubMed ID: 19652052
[No Abstract] [Full Text] [Related]
34. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
[TBL] [Abstract][Full Text] [Related]
35. Li-Fraumeni syndrome.
Santoro PM; Parker M; Szumel R
Del Med J; 2013 Sep; 85(9):275-7. PubMed ID: 24367873
[No Abstract] [Full Text] [Related]
36. [Familial cancer. 2. The S.B.L.A. syndrome: sarcoma of the breast, brain, leukemia and adrenals].
Philippe P
Union Med Can; 1985 Jun; 114(6):476-80. PubMed ID: 4024369
[No Abstract] [Full Text] [Related]
37. Clinical factors used to support prophylactic mastectomy for a male BRCA2 mutation carrier.
Guiahi M; Gabram SG; Albain KS; Camacho P; Krishnamachari B; Rajan P
Surgery; 2006 May; 139(5):704-6. PubMed ID: 16701105
[No Abstract] [Full Text] [Related]
38. Two families with the Li-Fraumeni cancer family syndrome.
Pearson AD; Craft AW; Ratcliffe JM; Birch JM; Morris-Jones P; Roberts DF
J Med Genet; 1982 Oct; 19(5):362-5. PubMed ID: 6958872
[TBL] [Abstract][Full Text] [Related]
39. A rare tumor and an ethical dilemma in a family with a germline TP53 mutation.
Prochazkova K; Foretova L; Sedlacek Z
Cancer Genet Cytogenet; 2008 Jan; 180(1):65-9. PubMed ID: 18068537
[TBL] [Abstract][Full Text] [Related]
40. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
